DaShenLin Pharmaceutical Group Co., Ltd.

XSSC:603233 Stock Report

Market Cap: CN¥19.7b

DaShenLin Pharmaceutical Group Valuation

Is 603233 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 603233 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 603233 (CN¥17.3) is trading below our estimate of fair value (CN¥37.82)

Significantly Below Fair Value: 603233 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 603233?

Other financial metrics that can be useful for relative valuation.

603233 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.8x
Enterprise Value/EBITDA14.1x
PEG Ratio0.9x

Price to Earnings Ratio vs Peers

How does 603233's PE Ratio compare to its peers?

The above table shows the PE ratio for 603233 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average34.3x
603883 LBX Pharmacy Chain
18.1x18.3%CN¥15.3b
603939 Yifeng Pharmacy Chain
21.2x18.2%CN¥32.2b
002727 Yixintang Pharmaceutical Group
56.9x46.4%CN¥8.9b
301408 Anhui Huaren Health Pharmaceutical
41.1xn/aCN¥5.5b
603233 DaShenLin Pharmaceutical Group
23.2x25.5%CN¥19.7b

Price-To-Earnings vs Peers: 603233 is good value based on its Price-To-Earnings Ratio (23.2x) compared to the peer average (34.3x).


Price to Earnings Ratio vs Industry

How does 603233's PE Ratio compare vs other companies in the CN Consumer Retailing Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a44.5%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a44.5%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 603233 is good value based on its Price-To-Earnings Ratio (23.2x) compared to the CN Consumer Retailing industry average (25.1x).


Price to Earnings Ratio vs Fair Ratio

What is 603233's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

603233 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio23.2x
Fair PE Ratio26x

Price-To-Earnings vs Fair Ratio: 603233 is good value based on its Price-To-Earnings Ratio (23.2x) compared to the estimated Fair Price-To-Earnings Ratio (26x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 603233 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥17.30
CN¥20.71
+19.7%
25.9%CN¥31.50CN¥12.00n/a9
Nov ’25CN¥15.94
CN¥20.38
+27.8%
27.2%CN¥31.50CN¥12.00n/a9
Oct ’25CN¥16.29
CN¥23.74
+45.7%
25.9%CN¥32.00CN¥16.00n/a8
Sep ’25CN¥13.51
CN¥27.91
+106.6%
16.3%CN¥32.00CN¥19.90n/a7
Aug ’25CN¥12.87
CN¥30.16
+134.3%
11.3%CN¥34.00CN¥22.50n/a9
Jul ’25CN¥14.74
CN¥31.54
+114.0%
5.2%CN¥34.00CN¥28.30n/a9
Jun ’25CN¥20.07
CN¥32.30
+60.9%
6.6%CN¥35.00CN¥28.30n/a8
May ’25CN¥21.78
CN¥32.99
+51.5%
9.0%CN¥38.00CN¥28.30n/a8
Apr ’25CN¥21.64
CN¥33.79
+56.1%
8.5%CN¥38.00CN¥28.90n/a9
Mar ’25CN¥23.37
CN¥34.40
+47.2%
7.1%CN¥38.00CN¥29.00n/a8
Feb ’25CN¥23.01
CN¥34.40
+49.5%
7.1%CN¥38.00CN¥29.00n/a8
Jan ’25CN¥24.90
CN¥34.65
+39.2%
7.7%CN¥38.00CN¥29.00n/a8
Dec ’24CN¥26.00
CN¥34.94
+34.4%
8.0%CN¥38.00CN¥29.00n/a7
Nov ’24CN¥24.34
CN¥36.12
+48.4%
4.4%CN¥38.33CN¥34.00CN¥15.948
Oct ’24CN¥25.15
CN¥36.74
+46.1%
4.5%CN¥38.50CN¥34.00CN¥16.298
Sep ’24CN¥26.37
CN¥36.76
+39.4%
4.5%CN¥38.50CN¥34.00CN¥13.518
Aug ’24CN¥27.90
CN¥37.23
+33.4%
6.0%CN¥41.25CN¥34.00CN¥12.878
Jul ’24CN¥28.01
CN¥38.50
+37.5%
6.3%CN¥41.67CN¥35.00CN¥14.747
Jun ’24CN¥26.95
CN¥39.77
+47.6%
8.5%CN¥45.83CN¥35.00CN¥20.078
May ’24CN¥28.68
CN¥41.32
+44.1%
5.8%CN¥45.83CN¥38.33CN¥21.786
Apr ’24CN¥31.02
CN¥42.00
+35.4%
5.1%CN¥45.83CN¥39.17CN¥21.645
Mar ’24CN¥31.66
CN¥42.50
+34.2%
5.4%CN¥45.83CN¥39.17CN¥23.375
Feb ’24CN¥31.80
CN¥41.33
+30.0%
6.3%CN¥45.83CN¥38.33CN¥23.015
Jan ’24CN¥33.00
CN¥38.42
+16.4%
19.9%CN¥45.83CN¥23.75CN¥24.905
Dec ’23CN¥36.42
CN¥38.42
+5.5%
19.9%CN¥45.83CN¥23.75CN¥26.005
Nov ’23CN¥30.13
CN¥34.80
+15.5%
21.7%CN¥41.67CN¥23.75CN¥24.345

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies